Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Angelo

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal of Surgical Oncology|October 13, 2020
Metaplastic breast cancer: Prognostic and therapeutic considerationsGiovanni Corso, Samuele Frassoni, Antonia Girardi, et al.
Cardiovascular and Interventional Radiology|October 6, 2025
Cost-Benefit Analysis of Trans-Arterial Radio-Embolization with Y-90 Glass Microspheres Versus Drug-Eluting Bead Trans-Arterial Chemo-Embolization in Patients with Hepatocellular Carcinoma in ItalyCarla Rognoni, Sherry Bhoori, Laura Crocetti, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancerFederico Cappuzzo, Alessandro Morabito, Nicola Normanno, et al.
Nature Genetics|May 27, 2017
Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta, et al.
Oncotarget|September 17, 2017
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib <i>versus</i> chemotherapy in advanced non-small cell lung cancer patientsLucia Kim, Mauro Saieg, Massimo Di Maio, et al.
Nature Genetics|January 24, 2017
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry ExperienceKalliopi Andrikou, Paola Ulivi, Elisabetta Petracci, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 30, 2020
Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion - a multi-center retrospective cohort studyMichela Assalino, Sylvain Terraz, Michal Grat, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2026
B-cell and plasma cell proliferations associated with T follicular helper cell lymphomas: clinical-pathological and genetic featuresMarco Pizzi, Luisa Lorenzi, Andrea De Crescenzo, et al.
Cancer Treatment Reviews|August 15, 2025
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research groupGiovanni Corso, Sherry Shen, Carmen Criscitiello, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Surgical Oncology|October 13, 2020
Metaplastic breast cancer: Prognostic and therapeutic considerationsGiovanni Corso, Samuele Frassoni, Antonia Girardi, et al.
Cardiovascular and Interventional Radiology|October 6, 2025
Cost-Benefit Analysis of Trans-Arterial Radio-Embolization with Y-90 Glass Microspheres Versus Drug-Eluting Bead Trans-Arterial Chemo-Embolization in Patients with Hepatocellular Carcinoma in ItalyCarla Rognoni, Sherry Bhoori, Laura Crocetti, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancerFederico Cappuzzo, Alessandro Morabito, Nicola Normanno, et al.
Nature Genetics|May 27, 2017
Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta, et al.
Oncotarget|September 17, 2017
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib <i>versus</i> chemotherapy in advanced non-small cell lung cancer patientsLucia Kim, Mauro Saieg, Massimo Di Maio, et al.
Nature Genetics|January 24, 2017
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry ExperienceKalliopi Andrikou, Paola Ulivi, Elisabetta Petracci, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 30, 2020
Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion - a multi-center retrospective cohort studyMichela Assalino, Sylvain Terraz, Michal Grat, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2026
B-cell and plasma cell proliferations associated with T follicular helper cell lymphomas: clinical-pathological and genetic featuresMarco Pizzi, Luisa Lorenzi, Andrea De Crescenzo, et al.
Cancer Treatment Reviews|August 15, 2025
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research groupGiovanni Corso, Sherry Shen, Carmen Criscitiello, et al.
Pageof 7